| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 06.06. | Bluejay Diagnostics closes $8.5 million private placement | 1 | Investing.com | ||
| 06.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 03.06. | What's Going On With Bluejay Diagnostics Shares On Wednesday? | 3 | Benzinga.com | ||
| 02.06. | Bluejay Diagnostics raises $8.5M in private placement | 2 | Investing.com | ||
| 02.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
| 02.06. | Why Is Bluejay Diagnostics Stock Soaring Tuesday? | 7 | Benzinga.com | ||
| 02.06. | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | 506 | AFX News | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 02.06. | Bluejay Diagnostics partners with Argonaut for US manufacturing | 4 | Investing.com | ||
| 02.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership | 190 | GlobeNewswire (Europe) | ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing... ► Artikel lesen | |
| 02.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | 151 | GlobeNewswire (Europe) | ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes in critical care settings... ► Artikel lesen | |
| 07.05. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.04. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial | 266 | GlobeNewswire (Europe) | ACTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on rapid, near-patient testing, today announced the successful... ► Artikel lesen | |
| 16.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.03. | Bluejay Diagnostics, Inc.: Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 06.03. | Bluejay Diagnostics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 06.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.03. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook | 228 | GlobeNewswire (Europe) | ACTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical diagnostics company developing rapid near-patient tests to improve... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 28,740 | +3,83 % | Warum Carl Zeiss Meditec zum Wochenstart im Fokus erfahrener Anleger steht: Was große Adressen zum Wochenstart bereits wissen - Was ich dieses Wochenende analysiert habe | ||
| HIMS & HERS HEALTH | 32,020 | -0,44 % | Hims & Hers-Aktie +162%: Bereit für den nächsten Schub? | Die Hims & Hers-Aktie bleibt eine der spannendsten Turnaround-Storys im US-Healthcare-Sektor. Nach starker Erholung mitsamt Bruch des vorherigen Abwärtstrends konnten vom Februartief bis zum Junihoch... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,850 | -3,14 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 57,61 | -0,33 % | Earnings Preview: What To Expect From GE HealthCare Technologies' Report | ||
| CLOVER HEALTH INVESTMENTS | 4,550 | -1,52 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 |
WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| BUTTERFLY NETWORK | 7,100 | +0,71 % | BFLY's Embedded Partner Unveils Breakthrough in Brain Imaging Tech | ||
| BEYOND AIR | 0,465 | -0,64 % | Beyond Air Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update | Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased revenue by 66% YoY in the fiscal fourth quarter 2026 The Company is transitioning its year-end from... ► Artikel lesen | |
| AXOGEN | 41,080 | +1,51 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AETHLON MEDICAL | 0,720 | +1,41 % | AETHLON MEDICAL INC - S-1/A, General form for registration of securities | ||
| AVANOS MEDICAL | 22,000 | +0,92 % | Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger | ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced... ► Artikel lesen | |
| APYX MEDICAL | 3,840 | +2,13 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| ANGIODYNAMICS | 11,600 | 0,00 % | Reasons to Hold AngioDynamics Stock in Your Portfolio for Now | ||
| ANTERIS TECHNOLOGIES GLOBAL | 10,240 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | ||
| ADAPTHEALTH | 10,760 | 0,00 % | AdaptHealth says attackers sweet-talked their way into cloud systems and stole patient data | ||
| BONE BIOLOGICS | 1,420 | 0,00 % | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |